Hi, what are you looking for?
– In the 1st June 2014 edition of Israel’s good news: ECONOMY & BUSINESS Please help us out : Will you offer us a...
– I’ve been absent from the blog scene for around seven weeks due to illness – exactly the same amount of time as between...
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
– With falling stock prices resulting from falling sales, George Soros has decided that now was the time to invest in SodaStream. – –...
– In the 11th May 2014 edition of Israel’s good news: ECONOMY & BUSINESS GDP per capita hits new high. Israel’s gross domestic product...
– In the 4th May 2014 edition of Israel’s good news: ECONOMY & BUSINESS Israel is the place to become a billionaire. A report...
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
– – Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Shlomo Yanai has been appointed chairman of US drug development company Cambrex Corporation (NYSE: CBM). He...
– – Dr. Phillip Frost’s , Opko Health (NYSE: OPK) , revealed that it agreed to pay $10 million for the Israeli Inspiro Medical, a next...
– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug...